Danish registry study links cladribine to lower short-term MS relapse rates
A Danish nationwide registry study found lower short-term relapse rates and few confirmed disability-worsening events among people with relapsing–remitting multiple ...
Tag: real-world study
Finerenone Slows Kidney Decline in Non-Diabetic CKD, Real-World Study Finds
A 24-month real-world cohort study of 121 patients with non-diabetic chronic kidney disease found that finerenone initiation was associated with ...
Gastric Cancer Drug Zolbetuximab Drives Widespread Albumin Loss in Real-World Patients
A real-world study finds that every patient treated with zolbetuximab for CLDN18.2-positive advanced gastric cancer developed hypoalbuminemia, with prior total ...
Ustekinumab Works Best in Crohn’s Disease Patients New to Biologics, Real-World Study Finds
A retrospective study of 61 Crohn's disease patients in China found that ustekinumab delivers stronger inflammatory control and endoscopic healing ...
Dual Cytokine Blocker Keeps Hidden Psoriasis at Bay for Two Full Years
A two-year Japanese real-world study of 66 patients shows the dual IL-17A and IL-17F inhibitor bimekizumab sustained high clearance rates ...
Machine Learning Reveals Three Diabetes Patient Types Shaping Heart and Kidney Drug Choices
A real-world study of 9000 patients with type 2 diabetes in China used cluster analysis to identify three clinical phenotypes ...
Eight Minutes to Relief: Rapid IV Opioid Titration Shows Striking Results in Palliative Care Crises
A Swiss real-world study of 38 palliative care patients found that rapid intravenous opioid titration reduced median pain scores from ...
Adding Brain Radiotherapy to Targeted Drugs Extends Survival in Lung Cancer Patients with Brain Metastases
A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...
Early Fostamatinib Use Shows High Response Rates in Immune Thrombocytopenia
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
Antibody-Drug Conjugate Combo Delivers 92.6% Complete Response Rate in Low-Risk Lymphoma Patients
A multicenter Chinese real-world study found that the antibody-drug conjugate regimen Pola-R-CHP achieved a 92.6 percent complete response rate in ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!